# Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium

> **NCT04745195** · — · RECRUITING · sponsor: **Maastricht University Medical Center** · enrollment: 42 (estimated)

## Conditions studied

- Thrombotic Microangiopathies
- Hemolytic Uremic Syndrome, Atypical
- Hemolytic-Uremic Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04745195
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-11
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04745195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04745195, "Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04745195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*